2019\u5e749\u67082\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ) \u306f\u3001Novartis\u793e\u524dCEO\u306eJoe Jimenez\u6c0f\u3068Eli Lilly and Company\u793e\u533b\u85ac\u54c1\u958b\u767a\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u306eRob Metcalf\u6c0f\u304c\u30012019 ³Ô¹Ï±¬ÁÏ R&D Summit<\/a><\/strong>\u306b\u57fa\u8abf\u8b1b\u6f14\u8005\u3068\u3057\u3066\u767b\u58c7\u3059\u308b\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u4e21\u6c0f\u306b\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u3067\u306e\u9769\u65b0\u7684\u306a\u5275\u85ac\u306b\u304a\u3051\u308b\u6700\u5148\u7aef\u3067\u6d3b\u8e8d\u3059\u308b\u30d3\u30b8\u30e7\u30ca\u30ea\u30fc\u3068\u3057\u3066\u3001\u696d\u754c\u5168\u4f53\u3067\u88fd\u54c1\u958b\u767a\u3092\u52a0\u901f\u3055\u305b\u308b\u6a5f\u4f1a\u306b\u3064\u3044\u3066\u8b1b\u6f14\u3057\u3066\u3044\u305f\u3060\u304d\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n Metcalf\u6c0f\u306f9\u67089\u65e5\u6708\u66dc\u65e5\u306b\u767b\u58c7\u3057\u3001\u5927\u624b\u88fd\u85ac\u4f01\u696d\u306b\u304a\u3051\u308b\u7814\u7a76\u958b\u767a\u7d44\u7e54\u306e\u904b\u55b6\u306e\u8907\u96d1\u3055\u3068\u305d\u306e\u7d4c\u9a13\u304b\u3089\u5b66\u3093\u3060\u3053\u3068\u306b\u3064\u3044\u3066\u8a9e\u308a\u307e\u3059\u3002\u307e\u305f\u3001\u3069\u306e\u3088\u3046\u306b\u9769\u65b0\u7684\u306a\u79d1\u5b66\u6280\u8853\u306e\u63d0\u4f9b\u3092\u8fc5\u901f\u5316\u3057\u3001\u9069\u5207\u306a\u533b\u85ac\u54c1\u3092\u9069\u5207\u306a\u60a3\u8005\u306b\u5b89\u5168\u304b\u3064\u52b9\u7387\u7684\u306b\u5c4a\u3051\u308b\u304b\u306b\u3064\u3044\u3066\u3082\u7d39\u4ecb\u3057\u307e\u3059\u3002<\/p>\n \u706b\u66dc\u65e5\u306b\u306f\u3001\u305d\u306e\u7814\u7a76\u958b\u767a\u3078\u306e\u53d6\u308a\u7d44\u307f\u306b\u3088\u3063\u3066Novartis\u793e\u306b\u696d\u754c\u6700\u5927\u898f\u6a21\u306e\u81ea\u793e\u5275\u85ac\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3092\u3082\u305f\u3089\u3057\u305fJimenez\u6c0f\u304c\u767b\u58c7\u3057\u3001\u7570\u7a2e\u79fb\u690d\u306b\u91cd\u70b9\u7684\u306b\u53d6\u308a\u7d44\u3080\u6700\u5148\u7aef\u30d0\u30a4\u30aa\u4f01\u696d\u3067\u3042\u308beGenesis\u793eCEO\u306ePaul Sehkri\u6c0f\u3068\u3068\u3082\u306b\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u306b\u304a\u3051\u308b\u60a3\u8005\u3078\u306e\u8ca2\u732e\u3084\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u7814\u7a76\u958b\u767a\u306a\u3069\u3078\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u30a4\u30f3\u30d1\u30af\u30c8\u306b\u3064\u3044\u3066\u3001\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u3092\u884c\u3044\u307e\u3059\u3002<\/p>\n \u3055\u3089\u306b\u3001\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u3001\u533b\u7642\u6a5f\u5668\u4f01\u696d\u304a\u3088\u3073\u8a3a\u65ad\u85ac\u4f01\u696d\u304b\u308955\u4eba\u4ee5\u4e0a\u304c\u3001³Ô¹Ï±¬ÁÏ\u306e\u81e8\u5e8a\u958b\u767a\u30fb\u85ac\u4e8b\u30fb\u54c1\u8cea\u696d\u52d9\u7528\u7d71\u5408\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u3067\u88fd\u54c1\u958b\u767a\u3092\u8fc5\u901f\u5316\u3057\u305f\u3001\u30d9\u30b9\u30c8\u30d7\u30e9\u30af\u30c6\u30a3\u30b9\u3092\u7d39\u4ecb\u3057\u307e\u3059\u3002\u6ce8\u76ee\u306e\u30bb\u30c3\u30b7\u30e7\u30f3\u306f\u4e0b\u8a18\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n 2019 ³Ô¹Ï±¬ÁÏ R&D Summit\u306f\u30012019\u5e749\u67088\uff5e10\u65e5\u306b\u30da\u30f3\u30b7\u30eb\u30d9\u30cb\u30a2\u5dde\u30d5\u30a3\u30e9\u30c7\u30eb\u30d5\u30a3\u30a2\u3067\u958b\u50ac\u3055\u308c\u307e\u3059\u30021,700\u4eba\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u3084\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u306e\u53c2\u52a0\u304c\u898b\u8fbc\u307e\u308c\u3066\u3044\u308b\u307b\u304b\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u3092\u727d\u5f15\u3059\u308b\u4f01\u696d\u306b\u3088\u308b75\u4ee5\u4e0a\u306e\u30bb\u30c3\u30b7\u30e7\u30f3\u304c\u4e88\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n Agios\u793e\u3001Alkermes\u793e\u3001Allergan\u793e\u3001Amgen\u793e\u3001Amicus Therapeutics\u793e\u3001Bioforum\u793e\u3001BioMarin Pharmaceutical\u793e\u3001Blueprint Medicines\u793e\u3001Bristol-Myers Squibb\u793e\u3001Cara Therapeutics\u793e\u3001Celularity\u793e\u3001\u7b2c\u4e00\u4e09\u5171\u793e\u3001Dicerna Pharmaceuticals\u793e\u3001\u30a8\u30fc\u30b6\u30a4\u793e\u3001Eli Lilly and Company\u793e\u3001Foamix Pharmaceuticals\u793e\u3001Gilead\u793e\u3001Global Blood Therapeutics\u793e\u3001Insmed\u793e\u3001Janssen\u793e\u3001Lotus Pharmaceutical\u793e\u3001Melinta Therapeutics\u793e\u3001Merck Healthcare KGaA\u793e\u3001Myovant Sciences\u793e\u3001Penumbra\u793e\u3001PRA Health Sciences\u793e\u3001REGENXBIO\u793e\u3001Roche Diagnostics\u793e\u3001Sarah Cannon Research Institute\u793e\u3001TESARO\u793e\uff08\u00a0a GSK Company\uff09\u3001Louisville\u5927\u5b66\u3001Vericel\u793e\u3001Xencor\u793e\u3001Xeris Pharma\u793e<\/p>\n 2019 ³Ô¹Ï±¬ÁÏ R&D Summit\u306e\u30d7\u30e9\u30c1\u30ca\u30b9\u30dd\u30f3\u30b5\u30fc\u306fAccenture\u793e\u3001Amazon Web Services\u793e, Kinapse\u793e\u3001NNIT\u793e\u3001PWC\u793e\u3001\u304a\u3088\u3073Valiance\u793e\u3067\u3059\u3002\u30b4\u30fc\u30eb\u30c9\u30b9\u30dd\u30f3\u30b5\u30fc\u306fCGI\u793e\u3001Daelight Solutions\u793e\u3001Deloitte\u793e\u3001Eagle Productivity\u793e\u3001FME\u793e\u3001GenPact\u793e\u3001C3i Solutions\u793e\u3001LMK Clinical\u793e\u3001Ideagen PLC\u793e\u3001LPW Training Services\u793e\u3001MuleSoft\u793e\u3001SDL\u793e\u3001\u304a\u3088\u3073Trifecta\u793e\u3067\u3059\u3002\u30b7\u30eb\u30d0\u30fc\u30b9\u30dd\u30f3\u30b5\u30fc\u306fAppBus\u793e\u3001Base Life Sciences\u793e\u3001OnTheMove\u793e\u3001Pyxa Solutions\u793e\u3001\u304a\u3088\u3073Suvoda\u793e\u3067\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ R&D Summit\u306f\u3001³Ô¹Ï±¬ÁÏ\u306e\u304a\u5ba2\u69d8\u304a\u3088\u3073\u3054\u62db\u5f85\u5ba2\u69d8\u5411\u3051\u306e\u7121\u6599\u30a4\u30d9\u30f3\u30c8\u3067\u3059\u3002\u8a73\u7d30\u3001\u3054\u767b\u9332\u3001\u8a73\u3057\u3044\u30a2\u30b8\u30a7\u30f3\u30c0\u306b\u3064\u3044\u3066\u306f\u3001veeva.com\/R&DSummit<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n <\/p>\n <\/p>\n \u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Forward-looking Statements\u3011<\/strong> 2019\u5e749\u67082\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 …<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[322],"tags":[],"class_list":["post-42873","post","type-post","status-publish","format-standard","hentry","category-press-release"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n
\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067775\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended April 30, 2019. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"